Vivera Pharmaceuticals operates as an innovative pharmaceutical company in Newport Beach, California. The company specializes in advanced drug delivery systems, particularly the TABMELT sublingual technology, which has garnered global exclusivity. With a focus on science-driven solutions, Vivera holds multiple patents, including the smart dose-controlled electronic medical device ZICOH. The recent Notice of Allowance for the portable telemedicine station, MDZone, highlights the company's commitment to enhancing healthcare delivery.
Vivera Pharmaceuticals encompasses diverse divisions, including pharmaceutical, neurosciences, medical technology, biosciences, and advanced diagnostics. This vertical integration allows the company to maintain control over its patented technologies, manufacturing processes, and distribution channels. The Newport Beach location serves as a hub for innovation, ensuring that cutting-edge solutions reach healthcare providers and patients efficiently. Vivera's commitment to research and development positions it as a leader in the pharmaceutical industry.
The company prioritizes quality and efficacy in its products, striving to meet the evolving needs of the healthcare landscape. Vivera Pharmaceuticals continues to push boundaries with its innovative approaches, ensuring that it remains at the forefront of pharmaceutical advancements. The integration of technology and healthcare solutions reflects a forward-thinking mindset that benefits both healthcare professionals and patients. Connect with Vivera Pharmaceuticals at 4343 Von Karman Ave, Newport Beach, California, for exceptional pharmaceutical services and innovative healthcare solutions.
